Bharat Biotech to begin Phase-1 trials of its intranasal vaccine for COVID-19 in February-March

Besides Covaxin, Bharat Biotech has been actively working on developing another vaccine, for which it tied up with Washington University School of Medicine in St Louis for the novel "chimp-adenovirus" (Chimpanzee adenovirus), a single dose in tranasal vaccine for COVID-19.

from Moneycontrol Business News https://ift.tt/35nmL9L